Company

PinCell S.R.L.

Milan-based pre-clinical biotech developing anti-inflammatory therapies for orphan skin disorders and other dermatological diseases.

About

Founded in 2008 and headquartered in Milan, Italy, PinCell S.R.L. is a pre-clinical biotech focused on innovative anti-inflammatory therapies for dermatological diseases, particularly orphan skin disorders with unmet medical needs. Alessandra Marconi is the founder and Antonino Amato is CEO. In May 2020 the company raised EUR 1.65 mn in Seed funding led by Sofinnova Partners. It reported revenue of EUR 0 in 2019.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in